{"id":"84cacc56-8b65-4ff8-a7ba-456e915dddae","kind":"institutions","code":"UB-I3822","name":"RA Capital Management","nameBasis":"original-brand","summary":"Investment firm focused on biotechnology and healthcare.","description":"Investment firm focused on biotechnology and healthcare.","country":null,"category":null,"originalName":"RA Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:04:13.435Z","englishUpdatedAt":"2026-10-15T18:45:27.783Z","reviewedAt":"2026-10-15T18:45:27.783Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"9efdf935b1711e3645661d73e90bdd347cea2120ff6751766a951bcbbdce77ec","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"专注生物科技与医疗健康的投资机构。","sources":[],"related":[{"id":"012b0b52-17af-4d30-9e8c-80a80b69a5ef","kind":"news","code":"012b0b52-17af-4d30-9e8c-80a80b69a5ef","name":"Superluminal Medicines raises USD 120 million in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Superluminal Medicines完成1.2亿美元A轮融资","eventDate":"2024-09-09T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T09:54:27.118Z","englishUpdatedAt":"2026-10-15T17:19:59.178Z","reviewedAt":"2026-10-15T17:19:59.178Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"dad4fa4c64ac255cdb6fbb7b3cdf1ed0bfd304e3c8f6cb55d15dd5d95c6b3db7","companyId":"7c66c728-c0c9-4716-992b-f0a5fc8d890e","foundedYear":null,"logoUrl":null,"path":"/news/012b0b52-17af-4d30-9e8c-80a80b69a5ef"},{"id":"22da73b7-c7eb-4a01-b246-146e4f248acc","kind":"news","code":"22da73b7-c7eb-4a01-b246-146e4f248acc","name":"Superluminal Medicines raises USD 60 million in Series B financing","nameBasis":"translated-title","summary":"On 2026-09-03, according to Xiniu Data, Superluminal Medicines completed Series B financing, raising USD 60 million. Investors were lead investor BVF Partners, RA Capital Management, Perceptive Advisors, NVIDIA and others. The company is a provider of U.S. AI generation drugs services.","description":"","country":null,"category":null,"originalName":"Superluminal Medicines完成B轮融资，融资金额6000万美元","eventDate":"2026-09-03T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:42:26.621Z","englishUpdatedAt":"2026-10-15T20:50:21.999Z","reviewedAt":"2026-10-15T20:50:21.999Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e8e7b1b012c19476316906130fd4ae28ebac9db6102a8c78bc6bf24e9a1a83b0","companyId":"7c66c728-c0c9-4716-992b-f0a5fc8d890e","foundedYear":null,"logoUrl":null,"path":"/news/22da73b7-c7eb-4a01-b246-146e4f248acc"}],"path":"/institutions/ra-capital-management","structured":{"city":null,"country":"United States","location":null,"role":null,"category":null,"company":null},"definition":"RA Capital Management is a venture capital investor based in the United States with 2 recorded investments.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/ra-capital-management"}